Data Is King

In our world, data is king (if not God). It is the fundamental marker of our product’s success and patients’ quality of life. In order for nurses and physicians to rely on us, we need to deliver high-fidelity urine output data. The best way to hold ourselves accountable is clinical research. Given our 510(K) exempt pathway to market, we do not need clinical studies to commercialize. Nevertheless, we want our product to be up to nephrologist standards in order to avoid errors in manual urine output measurement. While one of many young medical device companies, our goal is to help continue the movement for improving standards of care. With well-established clinical standards, we can best partner with physicians and deliver the data they need to treat patients as well as perform critical research.

We are thrilled to have abstracts submitted to the AKI & CRRT Conference as well as the PAPS (Pacific Association of Pediatric Surgeons) conference. Moreover, we will be attending the AKI & CRRT Conference next week in San Diego where our abstract will be on display in the poster sessions. We are thrilled to exhibit our product for the first time and engage nephrologists about urine output and AKI. A passage from our AKI & CRRT abstract reads:

"AKI impacts many aspects of patient’s quality of care: it increases mortality, cost of care, length of stay, and readmission rates. This condition can be prevented, or, once diagnosed, the severity can be limited, with earlier detection of urine output. Currently, urine output is measured in hourly intervals (often in intervals of 4 hours) through a transparent, pliable plastic container. This method only detects 77% of low urine output episodes and requires ICU nurses to spend approximately 5% of their time measuring and recording urine output. This method also creates a significant burden to hospital systems, considering only 50% of patients who develop AKI actually receive timely and sufficient care per ICU management protocol."

We fully understand that larger companies have more access to funding for clinical research. With this in mind, we will continue to reach out to industry partners in attempt to form a collaborative effort on improving clinical studies. It is imperative that small and large companies work together to best deliver urine output data. Moreover, with reliable data, physicians can utilize superior diagnostic measurements to advance their research. Better data leads to better quality of care.